N-(3-(1H-Imidazol-1-yl)propyl)-N-(4,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide hydrochloride

Catalog No. :
ACTKJO842
CAS No. :
1216724-11-6
Molecular Formula :
C24H25ClN4O3S
Molecular Weight :
485.01

IUPAC Name:N-(3-(1H-imidazol-1-yl)propyl)-N-(4,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide hydrochloride

N-(3-(1H-Imidazol-1-yl)propyl)-N-(4,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(1H-Imidazol-1-yl)propyl)-N-(4,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide hydrochloride
IUPAC NameN-(3-(1H-imidazol-1-yl)propyl)-N-(4,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide hydrochloride
Molecular FormulaC24H25ClN4O3S
Molecular Weight485.01
SMILESO=C(C1=CC=C2OCCOC2=C1)N(CCCN3C=CN=C3)C4=NC5=C(C)C=CC(C)=C5S4.[H]Cl
InChI KeyCRAZMWOXKBTKIR-UHFFFAOYSA-N
SynonymN-(4,7-dimethyl-1,3-benzothiazol-2-yl)-N-(3-imidazol-1-ylpropyl)-2,3-dihydro-1,4-benzodioxine-6-carboxamide:hydrochloride
CAS No.1216724-11-6

Synthetic Route by SureRoute

1. ACTKJO842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKJO842 route product structure diagram
    ACTKJO8421216724-11-6
Inquiry

2. ACTKJO842 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAJIN238 route compound structure diagram
    ACAJIN2384442-54-0 In Stock
  4. Then
  5. ACTKJO842 route product structure diagram
    ACTKJO8421216724-11-6
Inquiry

Comments (0)